This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Once-a-year shot for HIV protection passes early safety trial
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical Phase I testing trial and now may become a highly-effective and convenient form of HIV prevention.
Gilead data suggest once-yearly shot of PrEP drug blocks HIV infection
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a
HIV drug could offer yearlong protection with a single shot
A new formulation of Gilead's HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection. The study, published in The Lancet, evaluated the pharmacokinetics, safety and tolerability of two intramuscular formations of lenacapavir in participants ages 18-55 without HIV.
Gilead presents data for once-yearly lenacapavir for HIV prevention
Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of
Annual jab for HIV protection passes trial hurdle
If future trials go well - now it has passed the first, Phase I, testing hurdle - it could become the longest-acting form of HIV prevention available. Currently, people can take daily pills or sometimes have injections every eight weeks,
Newspoint on MSN2d
Get one injection in a year and get rid of the tension of HIV! It can be a boon for such people
Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...
MIT Technology Review1d
The Download: HIV prevention shots, and fixing a broken sex doll
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
STAT3d
SAMHSA employees detail an agency in shambles
Primarily a grantmaking agency with an $8 billion budget, SAMHSA channels funds and training that the federal government ...
EurekAlert!11d
New HIV vaccine candidate discovered with help from Argonne’s Advanced Photon Source
Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.
allAfrica.com on MSN3d
US funding cuts imperil search for HIV vaccine
A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...
Daily Maverick on MSN3d
US funding cuts imperil African search for HIV vaccine
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...